Litcius/Paper detail

Nirsevimab: First Approval

Susan J. Keam

2022Drugs111 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePalivizumabMonoclonal antibodyLower respiratory tract infectionVirologyRecombinant DNAVirusPharmacotherapyAntibodyRespiratory systemDiseaseFood and drug administrationRespiratory tract infectionsPharmacologyPediatricsInternal medicineImmunologyBiologyGeneBiochemistryRespiratory viral infections researchPneumonia and Respiratory InfectionsViral gastroenteritis research and epidemiology
Nirsevimab: First Approval | Litcius